**Core Concept**
Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor used in the treatment of erectile dysfunction (ED) and pulmonary arterial hypertension (PAH). PDE5 is an enzyme found primarily in the smooth muscle cells of the penis and in the pulmonary arteries.

**Why the Correct Answer is Right**
Sildenafil works by selectively inhibiting PDE5, which breaks down cyclic guanosine monophosphate (cGMP) in the penis. cGMP is a key signaling molecule involved in smooth muscle relaxation and vasodilation. By inhibiting PDE5, sildenafil increases the levels of cGMP, leading to smooth muscle relaxation and increased blood flow to the penis, resulting in erection. In the case of PAH, sildenafil also increases cGMP levels, causing vasodilation of the pulmonary arteries and reducing pulmonary artery pressure.

**Why Each Wrong Option is Incorrect**
**Option A:** PDE2 is involved in the regulation of cGMP and cAMP levels in the brain, particularly in the regulation of dopamine and cGMP-mediated signaling. Inhibiting PDE2 would not be beneficial for treating ED or PAH.
**Option B:** PDE4 is involved in the regulation of cAMP levels in inflammatory cells and is a target for treating inflammatory diseases such as asthma and rheumatoid arthritis. Inhibiting PDE4 would not be beneficial for treating ED or PAH.
**Option D:** PDE3 is involved in the regulation of cAMP levels in the heart and is a target for treating heart failure. Inhibiting PDE3 would not be beneficial for treating ED or PAH.

**Clinical Pearl / High-Yield Fact**
Sildenafil's mechanism of action is a classic example of targeting a specific enzyme to produce a therapeutic effect. This approach is commonly used in pharmacology to develop new treatments for various diseases.

**✓ Correct Answer: C. Inhibits PDE 5**